HIV Among Injection Drug Users in Large US Metropolitan Areas, 1998
Open Access
- 6 July 2005
- journal article
- Published by Springer Nature in Journal of Urban Health
- Vol. 82 (3), 434-445
- https://doi.org/10.1093/jurban/jti088
Abstract
This article estimates HIV prevalence rates among injection drug users (IDUs) in 95 large US metropolitan areas to facilitate social and policy analyses of HIV epidemics. HIV prevalence rates among IDUs in these metropolitan areas were calculated by taking the mean of two estimates: (1) estimates based on regression adjustments to Centers for Disease Control and Prevention (CDC) Voluntary HIV Counseling and Testing data and (2) estimates based on the ratio of the number of injectors living with HIV to the number of injectors living in the metropolitan area. The validity of the resulting estimates was assessed. HIV prevalence rates varied from 2 to 28% (median 5.9%; interquartile range 4.0–10.2%). These HIV prevalence rates correlated with similar estimates calculated for 1992 and with two theoretically related phenomena: laws against over-the-counter purchase of syringes and income inequality. Despite limitations in the accuracy of these estimates, they can be used for structural analyses of the correlates, predictors and consequences of HIV prevalence rates among drug injectors in metropolitan areas and for assessing and targeting the service needs for drug injectors.Keywords
This publication has 25 references indexed in Scilit:
- An HIV prevalence-based model for estimating urban risk populations of injection drug users and men who have sex with menJournal of Urban Health, 2004
- The association between knowledge of hepatitis C virus status and risk behaviors in injection drug usersAddiction, 2002
- Syringe type and drug injector risk for HIV infection: a case study in TexasSocial Science & Medicine, 2002
- The risk environment for HIV transmission: Results from the Atlanta and Flagstaff network studiesJournal of Urban Health, 2001
- Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment.2001
- Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatusAIDS, 2000
- Low Estimates of HIV Seroconversions Among Clients of a Drug Treatment Clinic in San Francisco, 1995 to 1998JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.American Journal of Public Health, 1998
- HIV Prevalence Among Injection Drug Users in Three Northern California CommunitiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Drug-assistance programs funded by Title II of the Ryan White CARE Act: a survey of the states.1996